OH2

BIOLOGICAL2 trials

Sponsors

Binhui Biopharmaceutical Co., Ltd.

Conditions

Advanced Colorectal CarcinomaMelanoma

Phase 2

First-line Maintenance of OH2 Injection for Advanced Colorectal Cancer

TerminatedNCT05648006

Binhui Biopharmaceutical Co., Ltd.Advanced Colorectal Carcinoma

Start: 2023-10-17End: 2024-04-15Updated: 2024-04-30

Phase 3

OH2 Injection in Melanoma

RecruitingNCT05868707

Binhui Biopharmaceutical Co., Ltd.Melanoma

Start: 2023-03-08End: 2027-03-31Target: 340Updated: 2025-07-25

Related Papers

Oncolytic virus OH2 extends survival in patients with PD-1 pretreated melanoma: phase Ia/Ib trial results and biomarker insights

Journal for ImmunoTherapy of Cancer2025-02-0115 citations